It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or
consider using other browsers such as Chrome, Firefox or Safari.
Omnitrope is a laboratory-created human growth hormone and has 6 indications to address a wide variety of growth hormone disorders.
It is indicated for people with:
Growth failure due to growth hormone deficiency (GHD)
Small for gestational age
Idiopathic short stature
At OmniSource, we’re committed to helping your patient to start and stay on treatment. From insurance to home injections, we understand the obstacles that can arise along the way, and we’re here to make their growth journey as smooth as possible.
Our comprehensive patient support program includes access to:
OmniSource Case Manager (OCM)
Benefits Investigation (BI) and Prior Authorization (PA) Support
Sandoz OmniStart Program*
Co-Pay Savings Program†
Omnitrope Starter Kits
Get them started off on the right foot! Find out more about our comprehensive OmniSource support services here.
The OmniSource Team provides personalized support services to help your patients each step of the way.
The OmniSource team is here to help make the insurance process as smooth as possible.
We’re committed to serving a wide variety of patients prescribed growth hormone.
Personalized support, each step of the way. Click here to enroll your patient.
Omnitrope® is a recombinant human growth hormone indicated for:
Please see full Prescribing Information for Omnitrope.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch